Warning: The NCBI web site requires JavaScript to function. more...
Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.
Jangro WC, Preval H, Southard R, Klotz SG, Francis A.
Child Adolesc Psychiatry Ment Health. 2009 Mar 12;3(1):9.
Related citations
Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I, Preval H, Southard R, Francis A.
Am J Geriatr Pharmacother. 2005 Dec;3(4):240-5.
The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
Mendelowitz AJ.
Ann Clin Psychiatry. 2004 Jul-Sep;16(3):145-54.
Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.
Preval H, Klotz SG, Southard R, Francis A.
Gen Hosp Psychiatry. 2005 Mar-Apr;27(2):140-4.
Best clinical practice with ziprasidone IM: update after 2 years of experience.
Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R.
CNS Spectr. 2005 Sep;10(9):1-15. Review.
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP.
Psychopharmacology (Berl). 2001 May;155(2):128-34.
Pharmacological management of acute agitation.
Battaglia J.
Drugs. 2005;65(9):1207-22. Review.
Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
Currier GW, Simpson GM.
J Clin Psychiatry. 2001 Mar;62(3):153-7.
The expert consensus guideline series. Treatment of behavioral emergencies 2005.
Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP; Expert Consensus Panel for Behavioral Emergencies 2005.
J Psychiatr Pract. 2005 Nov;11 Suppl 1:5-108; quiz 110-2.
Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Brook S.
J Clin Psychiatry. 2003;64 Suppl 19:13-8. Review.
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW.
J Psychiatr Pract. 2006 Mar;12(2):103-8.
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses.
Belgamwar RB, Fenton M.
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003729. Review.
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
Khan SS, Mican LM.
J Child Adolesc Psychopharmacol. 2006 Dec;16(6):671-7.
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Brook S, Walden J, Benattia I, Siu CO, Romano SJ.
Psychopharmacology (Berl). 2005 Apr;178(4):514-23. Epub 2005 Jan 14.
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, Gharabawi GM.
J Clin Psychiatry. 2004 Mar;65(3):386-94.
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA.
J Clin Psychiatry. 2007 Jan;68(1):111-9.
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
Daniel DG, Zimbroff DL, Swift RH, Harrigan EP.
Int Clin Psychopharmacol. 2004 Jan;19(1):9-15.
Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM.
CNS Drugs. 2002;16(9):645-52. Review.
A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.
Clin Ther. 2003 May;25(5):1420-8.
Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
Cañas F.
Eur Neuropsychopharmacol. 2007 Mar;17 Suppl 2:S108-14. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on